KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Other Gross PP&E Adjustments (2016 - 2025)

Neogenomics' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $210.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 4.92% year-over-year to $210.5 million; the TTM value through Dec 2025 reached $210.5 million, up 4.92%, while the annual FY2025 figure was $210.5 million, 4.92% up from the prior year.
  • Other Gross PP&E Adjustments reached $210.5 million in Q4 2025 per NEO's latest filing, up from -$87.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $210.5 million in Q4 2025 to a low of -$127.3 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$34.5 million, with a median of -$97.0 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 129.22% in 2021, then increased 28.76% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $114.9 million in 2021, then rose by 17.98% to $135.5 million in 2022, then rose by 14.99% to $155.8 million in 2023, then rose by 28.76% to $200.6 million in 2024, then grew by 4.92% to $210.5 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Other Gross PP&E Adjustments are $210.5 million (Q4 2025), -$87.8 million (Q3 2025), and -$98.1 million (Q2 2025).